Medicinal product name Tempidol 500 mg orodispersible tablets
Pharmaceutical form Orodispersible tablet
Strength 500 mg 
Information from the MAH on shortages Not notified
Legal status OTC OTC
Package leaflet MS Word document 23-02-2021
Summary of product characteristics MS Word document 23-02-2021
ATC code N02BE01 Analgesics

Important notice

Additional information regarding the use for persons aged 75+

If used as "ANALGESICS"
SubstanceClassComment
ParacetamolumASuitable for older persons. Maximum dose in regular use 2-3 g/day. Note paracetamol in OTC drugs and combination products. Overdose is hepatotoxic. Concurrent use with warfarin is possible if INR values are monitored.

Medicinal products (14)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10
(500 mg)
PVC/PVDC blister    10-0285-01 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N12
(500 mg)
PVC/PVDC blister    10-0285-02 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N16
(500 mg)
PVC/PVDC blister    10-0285-03 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N20
(500 mg)
PVC/PVDC blister    10-0285-04 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(500 mg)
PVC/PVDC blister    10-0285-05 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N50
(500 mg)
PVC/PVDC blister    10-0285-06 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(500 mg)
PVC/PVDC blister    10-0285-07 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10
(500 mg)
Aclar/PVC blister    10-0285-08 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N12
(500 mg)
Aclar/PVC blister    10-0285-09 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N16
(500 mg)
Aclar/PVC blister    10-0285-10 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N20
(500 mg)
Aclar/PVC blister    10-0285-11 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30
(500 mg)
Aclar/PVC blister    10-0285-12 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N50
(500 mg)
Aclar/PVC blister    10-0285-13 Labelling text Labelling text Feb 23, 2021
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(500 mg)
Aclar/PVC blister    10-0285-14 Labelling text Labelling text Feb 23, 2021

Registration information

Marketing authorisation No. 10-0285
MA suspended from the medicinal product register by request of Actavis Group PTC ehf., Iceland Dec 16, 2021
Permitted to distribute until Jun 16, 2022
Marketing authorisation holder, country Actavis Group PTC ehf., Iceland